Close Window

Digital Look Email A Friend

Novartis to buy US biopharmaceutical firm Avidity for $12bn

Published by Michele Maatouk on 27th October 2025

(Sharecast News) - Switzerland's Novartis has agreed to buy San Diageo-based biopharmaceutical firm Avidity Biosciences for $12bn in cash.

URL: http://www.digitallook.com/dl/news/story/35449208/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.